Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
09/2003
09/09/2003CA2263566C Substituted 6,5-hetero-bicyclic derivatives
09/04/2003WO2003072715A2 Gasp1: a follistatin domain containing protein
09/04/2003WO2003072714A2 Follistatin domain containing proteins
09/04/2003WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/04/2003WO2003072579A1 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
09/04/2003WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
09/04/2003WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003WO2003072110A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003072090A2 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003WO2003072060A2 Polypeptide formulation
09/04/2003WO2003072055A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003WO2003071922A2 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
09/04/2003WO2003064472A3 Treatment of ms with goat serum
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003045313A3 2-aminoquinoline compounds
09/04/2003WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002052002A3 Immunomodulatory polynucleotides and methods of using the same
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166872 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders
09/04/2003US20030166711 A non-peptide and a non- nucleotide compound, culture product of penicillium sp. SPF-3059
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166654 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/04/2003US20030166589 Method and pharmaceutical composition for the treatment of multiple sclerosis
09/04/2003US20030166582 Aryl fused azapolycyclic compounds
09/04/2003US20030166534 Suppressing a class II MHC-restricted immune response in a mammal, or in mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes,
09/04/2003US20030166300 Growth-related inflammatory and immune response protein
09/04/2003US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases
09/04/2003US20030165907 Human glycine transporter type 2
09/04/2003US20030165892 Unigene unidirectional antisense library
09/04/2003US20030165807 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
09/04/2003US20030165499 Compositions and methods for treating psoriasis
09/04/2003US20030165434 Delivery of polynucleotide agents to the central nervous system
09/04/2003CA2477218A1 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003CA2477111A1 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003CA2476887A1 Gasp1:a follistatin domain containing protein
09/04/2003CA2476654A1 Follistatin domain containing proteins
09/04/2003CA2475655A1 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
09/03/2003EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol
09/03/2003EP1339721A2 Hydroxyesters of 7-desmethylrapamycin
09/03/2003EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
09/03/2003EP1339405A1 Use of anti-muscarinic agents and calcium channel blockers in combination
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP1339398A2 Treatment of motor fluctuations with 5-hydroxytryptamine 1a receptor activity enhancing compounds
09/03/2003EP1133295B1 Use of nicergoline for treating spasmodism
09/03/2003EP1060178B1 Heterocyclic compounds as inhibitors of rotamase enzymes
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use
09/03/2003CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/03/2003CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders
09/03/2003CN1439417A External used medicine for traumatic injury and preparation thereof
09/03/2003CN1439382A Chinese medicinal herb paste for fractures and preparation thereof
09/02/2003US6613874 Melanocortin receptor ligands
09/02/2003US6613739 Immunosuppressants
08/2003
08/28/2003WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
08/28/2003WO2003070969A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070965A2 The eaat2 promoter and uses thereof
08/28/2003WO2003070918A2 Rna interference by modified short interfering nucleic acid
08/28/2003WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)
08/28/2003WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid
08/28/2003WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070731A2 Azabicyclic compounds for the treatment of disease
08/28/2003WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2003WO2003070243A1 Di-ester derivatives as short acting neuromuscular blockers
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003069997A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003WO2003016335A3 Irreversible cysteine protease inhibitors of legumain
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002040005A3 Blockade of sodium channels by phenol derivatives
08/28/2003WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162798 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 233